Background: Although the rate of carcinoma upgrade for atypical ductal hyperplasia
amount of tissue, there is a potential for underestimation of a malignant lesion as ADH. 2 For this reason, the current standard treatment after CNB diagnosis of ADH is surgical excision (SE). 8 The rates of upgrade to carcinoma reported in the literature range between 15% to 56%.
2,4-7,9-,15
There have been multiple studies evaluating pathological, radiological, and clinical features that may predict upgrade of ADH diagnosed on CNB. 2, [5] [6] [7] 10, 13 Predictive features identified by more than Sunnybrook Health Sciences Centre. Approval for the study was obtained from the ethics committee. ADH cases with other non-atypical and atypical proliferative lesions present in the same CNB specimens were included in this study. ADH cases with DCIS or invasive carcinomas present in the same CNB specimens were excluded. We included cases with known ipsilateral breast cancer at the time of the CNB; however, we ensured that the ADH was located away from the carcinoma as per imaging reports. Three breast pathologists (FL, ES, and SNM) blinded to the final SE diagnosis performed an independent slide review of cases meeting these criteria. Cases were included in the study if ≥2 pathologists agreed on the diagnosis of ADH. These cases were further reviewed for various histologic, radiologic, and clinical features ( 
| Radiological features
The only predictive feature was radiologic lesion size as assessed on the modality used for core needle biopsy (25.24 mm vs 12.07 mm, P = 0.0133).
| Clinical features
The predictive features were patient age (58 years vs 52 years, P = 0.0027), and personal history of concurrent or prior ipsilateral, 
| DISCUSSION
In our study, 62/124 (50%) ADH cases upgraded to carcinoma on SE. This upgrade rate is at the high end of the rates reported in the literatures. 2,4-7,9-,15 Our center is a tertiary referral center for breast oncology primarily involved in high-risk patient screenings, which may explain the high rate of carcinoma upgrade. Indeed, 54% of the cases in our study had 1 or more high-risk clinical features such as personal history of breast cancer, family history of breast or ovarian cancer, BRCA mutation carrier, and radiation exposure. Our pathologists may also be more hesitant to diagnose DCIS of limited histologic extent on CNB, as such diagnosis would imply the need for adjuvant radiation therapy, rather than SE alone.
Atypical ductal hyperplasia (ADH) specimen interpretation has a high rate of interobserver variability. [17] [18] [19] [20] This issue is a limitation of previous studies on ADH that did not include pathologic review of ADH diagnoses. To minimize variability in our study, a case was included only when there was majority agreement on the ADH diagnosis.
Of the 124 (20.2%) ADH cases, 35 had an original diagnosis of "At least ADH" or "ADH bordering on DCIS". These cases were significantly more likely to upgrade to carcinoma on SE than cases diag- Radiologic lesion size (mm) ≤5.9 6-9.9 10-19.9 ≥20
Patient age (years) ≤44.9 45-54.9 55-64.9 ≥65
to over 20 mm. 6, 7, 13, 16 Biopsy imaging modality and biopsy needle size were not found to be significant predictors in our study. However, our radiologists frequently compensate for the use of smaller biopsy needle or less specific imaging modality (eg, MRI) by submitting more cores and/or using larger biopsy needle in order to ensure adequate sampling of lesional area.
In our study, patient age was a significant predictor of upgrade,58 years in cases with upgrade versus 52 years in non-upgraded cases. Patient age was also identified as a predictor of carcinoma upgrade by other investigators, 2, 6, 7, 10, 13, 15 with the majority of these studies finding older age (over 50 years) to be predictive of malignancy. 3, 6, 7, 10 We also found that the presence of ipsilateral malignancy, whether other studies developed a predictive model to assess the risk of upgrade on SE following a CNB diagnosis of ADH. 13, 15 While their predictive models demonstrated fair to excellent accuracy in the patient samples used to develop the predictive models, the predictive models were either not validated in a separate patient sample, 15 or demonstrated poor accuracy when tested independently in a validation set. 9 
| CONCLUSION
A significant proportion of ADH cases diagnosed on CNB in our population upgraded to carcinoma on SE. Several pathologic, radiologic, and clinical features predicted carcinoma upgrade. A predictive model developed using this data has fair accuracy, and may be used to determine the risk of carcinoma upgrade on SE.
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